Schlafen 11 (SLFN11), a restriction factor for replicative stress induced by DNA-targeting anti-cancer therapies

Murai, J; Thomas, A; Miettinen, M; Pommier, Y

Murai, J (reprint author), Keio Univ, Inst Adv Biosci, 246-2 Mizukami, Tsuruoka, Yamagata 9970052, Japan.; Pommier, Y (reprint author), NIH, Bldg 37,Room 5068, Bethesda, MD 20892 USA.

PHARMACOLOGY & THERAPEUTICS, 2019; 201 (): 94

Abstract

Schlafen 11 (SLFN11) sensitizes cells to a broad range of anti-cancer drugs including platinum derivatives (cisplatin and carboplatin), inhibitors of ......

Full Text Link